GlobeImmune Inc (GBIM)
0.00
USD |
OTCM |
Apr 24, 16:00
GlobeImmune Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2014 | 21.11M |
| September 30, 2014 | 21.10M |
| June 30, 2014 | 6.476M |
| March 31, 2014 | 6.453M |
| December 31, 2013 | 0.0018M |
| Date | Value |
|---|---|
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| June 30, 2012 | 0.001M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.91M |
| Palatin Technologies Inc | 5.553M |
| iBio Inc | 10.68M |
| Theriva Biologics Inc | 0.625M |
| Oragenics Inc | 0.2839M |